期刊文献+

Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats 被引量:24

原文传递
导出
摘要 Background Excessive deposition of extraceUular matrix(ECM)in the kidney is the hallmark of diabetic nephropathy.Increased matrix synthesis has been well documented but the effects of diabetes on degradative pathways,particularly in the in vivo setting.The renal protective effect of these pathways on matrix accumulation has not been fully elucidated.The present study was understaken to investigate the activity of matrix metalloproteinase-2(MMP-2),the expression of MMP-2 and tissue inhibitor of metalloproteinase-2(TIMP-2)in kidney tissues of diabetic rats,and to explore the degradative pathway of typeⅣcollagen(Ⅳ-C)and the renal protective effects of ACE inhibition-benazepril.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第10期814-821,共8页 中华医学杂志(英文版)
基金 This study was supported by a grant from the Natural Science Foundation of Shandong Province(No.Y2002C35).
  • 相关文献

参考文献13

  • 1N. L. Alderson,M. E. Chachich,N. Frizzell,P. Canning,T. O. Metz,A. S. Januszewski,N. N. Youssef,A. W. Stitt,J. W. Baynes,S. R. Thorpe.Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat[J].Diabetologia.2004(8)
  • 2S. V. McLennan,D. J. Kelly,A. J. Cox,Z. Cao,J. G. Lyons,D. K. Yue,R. E. Gilbert.Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases[J].Diabetologia.2002(2)
  • 3S. Rudberg,R. ?sterby,H.-J. Bangstad,G. Dahlquist,B. Persson.Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus[J].Diabetologia.1999(5)
  • 4McLennan SV,Fisher EJ,Yue DK,Turtle JR.High glucose concentration causes a decreases in mesangium degradation[].Diabetes.1994
  • 5Deferrari G,Ravera M,Berruti V,Leoncini G,Deferrari L.Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment[].Journal of the American Society of Nephrology.2004
  • 6Miner JH.Renal basement membrane components[].Kidney International.1999
  • 7Singh R,Song RH,Alavi N,Pegoraro AA,Singh AK,Leehey DJ.High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1[].Experimental Nephrology.2001
  • 8Gilbert RE,Cox A,Wu LL,Allen TJ,Hulthen UL,Jerum S.Expression of transforming growth factor betal and type IV collagen in the renal tubuloin terstitium in experimental diabetes: effects of ACE inhibition[].Diabetes.1998
  • 9Border WA,Noble NA.Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy[].Kidney International.1998
  • 10Singh R,Alavi N,Singh AK,Leehey DJ.Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation[].Diabetes.1999

同被引文献103

引证文献24

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部